Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Enasidenib-Induced Differentiation Syndrome in IDH2-Mutant Acute Myeloid Leukemia.
What we have learned: the impact of quality from a clinical trials perspective.
See All 2 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
What we have learned: the impact of quality from a clinical trials perspective.
FitzGerald TJ. What we have learned: the impact of quality from a clinical trials perspective. Semin Radiat Oncol. 2012 Jan; 22(1):18-28.
View in:
PubMed
subject areas
Cancer Care Facilities
Clinical Protocols
Clinical Trials as Topic
Credentialing
Hodgkin Disease
Humans
Medical Informatics
National Cancer Institute (U.S.)
Quality Assurance, Health Care
Radiation Oncology
Research Design
United States
authors with profiles
Thomas J FitzGerald MD